Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Safety and Efficacy of Ciclesonide in Pediatric Patients (6 to 11 Years of Age) With Seasonal Allergic Rhinitis (BY9010/M1-417)

ClinicalTrials.gov ID: NCT00305487

Public ClinicalTrials.gov record NCT00305487. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 31, 2026, 6:50 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Clinical Trial Designed to Assess the Safety and Efficacy of Ciclesonide (200mcg and 100mcg, Once Daily) Applied as a Nasal Spray for Two Weeks in the Treatment of Seasonal Allergic Rhinitis (SAR) in Patients 6 to 11 Years of Age

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The aim of the study is to determine the efficacy and safety of ciclesonide nasal spray in children with seasonal allergic rhinitis. Ciclesonide will be administered intranasally at two dose levels once daily. The study consists of a baseline period (1 to 3 weeks) and a treatment period (2 weeks).

Study identification

NCT ID
NCT00305487
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
AstraZeneca
Industry
Enrollment
660 participants

Conditions and interventions

Eligibility (public fields only)

Age range
6 Years to 11 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 2006 (Type not available)
Primary completion
Oct 2006 (Actual)
Completion
Oct 2006 (Actual)
Last update posted
Nov 30, 2016

2006

United States locations

U.S. sites
71
U.S. states
28
U.S. cities
68
Facility City State ZIP Site status
Altana Pharma/Nycomed Birmingham Alabama 35235 —
Altana Pharma/Nycomed Hot Springs Arkansas 71913 —
Altana Pharma/Nycomed Costa Mesa California 92626 —
Altana Pharma/Nycomed Huntington Beach California 92647 —
Altana Pharma/Nycomed Long Beach California 90806 —
Altana Pharma/Nycomed Los Alamitos California 90720 —
Altana Pharma/Nycomed Mission Viejo California 92691 —
Altana Pharma/Nycomed Orange California 92868 —
Altana Pharma/Nycomed Roseville California 95678 —
Altana Pharma/Nycomed San Diego California 92120 —
Altana Pharma/Nycomed San Diego California 92123 —
Altana Pharma/Nycomed San Jose California 95117 —
Altana Pharma/Nycomed Stockton California 95207 —
Altana Pharma/Nycomed Colorado Springs Colorado 80907 —
Altana Pharma/Nycomed Denver Colorado 80230 —
Altana Pharma/Nycomed Englewood Colorado 80112 —
Altana Pharma/Nycomed Lakewood, CO Colorado 80401 —
Altana Pharma/Nycomed Atlanta Georgia 30342 —
Altana Pharma/Nycomed Gainesville Georgia 30501 —
Altana Pharma/Nycomed Savannah Georgia 31406 —
Altana Pharma/Nycomed Woodstock, GA Georgia 30188 —
Altana Pharma/Nycomed Normal Illinois 61761 —
Altana Pharma/Nycomed Indianapolis Indiana 46208 —
Altana Pharma/Nycomed Overland Park Kansas 66211 —
Altana Pharma/Nycomed Louisville, KY Kentucky 40215 —
Altana Pharma/Nycomed Metairie Louisiana 70006 —
Altana Pharma/Nycomed Shreveport Louisiana 71105 —
Altana Pharma/Nycomed Bethesda Maryland 20814 —
Altana Pharma/Nycomed North Dartmouth Massachusetts 02747 —
Altana Pharma/Nycomed Minneapolis Minnesota 55402 —
Altana Pharma/Nycomed Jefferson City Missouri 65109 —
Altana Pharma/Nycomed Rolla Missouri 65401 —
Altana Pharma/Nycomed St Louis Missouri 63141 —
Altana Pharma/Nycomed Lincoln, NE Nebraska 68505 —
Altana Pharma/Nycomed Papillion Nebraska 68046 —
Altana Pharma/Nycomed Brick New Jersey 08724 —
Altana Pharma/Nycomed Forked River New Jersey 08731 —
Altana Pharma/Nycomed Red Bank New Jersey 07701 —
Altana Pharma/Nycomed Skillman New Jersey 08558 —
Altana Pharma/Nycomed Warren Township New Jersey 07059 —
Altana Pharma/Nycomed Rochester, NY New York 14618 —
Altana Pharma/Nycomed Rockville Centre New York 11570 —
Altana Pharma/Nycomed Raleigh North Carolina 27607 —
Altana Pharma/Nycomed Cincinnati Ohio 45219 —
Altana Pharma/Nycomed Cincinnati, OH Ohio 45231 —
Altana Pharma/Nycomed Ashland Oregon 97520 —
Altana Pharma/Nycomed Lake Oswego Oregon 97035 —
Altana Pharma/Nycomed Medford, OR Oregon 97504 —
Altana Pharma/Nycomed Portland Oregon 97213 —
Altana Pharma/Nycomed Blue Bell Pennsylvania 19422 —
Altana Pharma/Nycomed Eerie Pennsylvania 16506 —
Altana Pharma/Nycomed Pittsburgh Pennsylvania 15202 —
Altana Pharma/Nycomed Pittsburgh Pennsylvania 15241 —
Altana Pharma/Nycomed Upland Pennsylvania 19013 —
Altana Pharma/Nycomed Charleston South Carolina 29414 —
Altana Pharma/Nycomed Charleston, SC South Carolina 29407 —
Altana Pharma/Nycomed Germantown Tennessee 38138 —
Altana Pharma/Nycomed Jackson Tennessee 38301 —
Altana Pharma/Nycomed Austin Texas 78731 —
Altana Pharma/Nycomed Austin Texas 78750 —
Altana Pharma/Nycomed Dallas Texas 75231 —
Altana Pharma/Nycomed El Paso Texas 79925 —
Altana Pharma/Nycomed Kerrville Texas 78028 —
Altana Pharma/Nycomed New Braunfels Texas 78130 —
Altana Pharma/Nycomed San Antonio Texas 78229 —
Altana Pharma/Nycomed Salt Lake City Utah 84037 —
Altana Pharma/Nycomed South Burlington Vermont 05403 —
Altana Pharma/Nycomed Burke Virginia 22015 —
Altana Pharma/Nycomed Charlottesville Virginia 22911 —
Altana Pharma/Nycomed Richmond Virginia 23226 —
Altana Pharma/Nycomed Milwaukee Wisconsin 53209 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00305487, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 30, 2016 · Synced Oct 31, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00305487 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →